Prostate Cancer

The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow growing, according to a recent study.

New research shows a significant decrease in PSA screening by primary care physicians since the release of the United States Preventive Services Task Force recommendation against screening in May 2012.

Outcomes following salvage radiation therapy after recurrent prostate cancer in a racially mixed cohort are no better when it’s started at a PSA level

Regular use of aspirin in the year before a diagnosis of stage I-III prostate cancer is associated with a reduction in prostate cancer-specific mortality, say Irish researchers.

African-American men are more influenced by convenience than are Caucasian men in their choice of treatment for early-stage prostate cancer, according to a recent study.

New therapies that are extending survival of men with metastatic castration-resistant prostate cancer may also be contributing to an increasing trend for the development of non-osseous metastatic disease in these patients, according to a recent study.

Researchers say a cooling device can reduce local inflammation and shorten time to continence-and even prevent permanent incontinence-in patients who undergo robot-assisted radical prostatectomy.

In an attempt to clarify what it calls conflicting guideline statements on prostate cancer screening from various organizations, the Large Urology Group Practice Association has issued its own position on the use of the PSA test as a screening tool.

In this case, the patient tried to keep the observing urologist in the case as another source of payment by claiming a physician-patient relationship existed, thus establishing he had a legal duty to ensure the care was within the accepted standard.

A recent study has linked genetic mutations to an increased risk of developing prostate cancer.

Even as the debate over the U.S. Preventive Services Task Force’s grade D recommendation for PSA screening continues, patients made their feelings clear about the recommendation in a recent survey.

Coffee consumption is associated with a lower risk of prostate cancer recurrence and progression, researchers reported.

For men aged 50–69 years, PSA testing reduces prostate cancer-specific mortality and the incidence of metastatic disease, according to a new multinational consensus statement on early detection of prostate cancer, which also calls for prostate cancer diagnosis to be unlinked from treatment for the disease.

Epigenetic profiling of prostate biopsies significantly improved the accuracy of predicting cancer in men with negative results, according to a late-breaking abstract presented at the AUA annual meeting in San Diego.

Combining a prostate cancer gene assay with standard risk-stratification factors substantially increased information to guide decision making about active surveillance, a validation study of the assay showed.

Findings from a meta-analysis, including data from five independent patient cohorts, show that a novel genetic test is a powerful prognostic predictor of prostate cancer outcome across diverse clinical settings.

The latest products and services from neoSurgical, Wiley-Blackwell, iURO, and USARAD.com.

Two new studies provide insights into aggressive prostate cancer that may suggest novel approaches to treatment.

A natural form of sugar could offer a new, noninvasive way to precisely image prostate and other tumors and potentially see whether cancer medication is effective, by means of a new imaging technology.

The advent of new biomarkers for prostate cancer could help determine the need for observation vs. interventional therapies.

The transition to ICD-10 is not just another thing on urologists’ plates. It’s the main course, and time to prepare for the change is running short.

Prostate cancer aggressiveness may be established when the tumor is formed and does not alter with time, according to a recent study.

After 18 years of follow-up, new findings from the Prostate Cancer Prevention Trial show that the 5-alpha-reductase inhibitor finasteride (Proscar) reduces the risk of prostate cancer by about one-third but has no effect on mortality risk.

Major organizations representing urology are livid at the conclusions of a new report by the U.S. Government Accountability Office, which basically accuses urology practices with in-office intensity-modulated radiation therapy facilities of ripping off Medicare.

Provision of intensity-modulated radiation therapy services performed by self-referring groups “increased rapidly” between 2006 and 2010 while the rate declined for non-self-referring groups, according to a report from the Government Accountability Office.

A group of scientists that includes a urologist is proposing a major update of the way the U.S. approaches diseases now classified as “cancer,” including eliminating that term from tumors considered indolent.

Men who receive decision aids about prostate cancer screening appear to have significantly increased knowledge about screening and less conflict about what to do, but the decision aids show little impact on their decision whether or not to be screened.

Men who are diagnosed with azoospermia are more prone to developing cancer than the general population, according to a recent study.

Drugs and devices in the pipeline from Targacept, Inc., Cubist, OncoGenex Pharmaceuticals, Inc., Apricus Biosciences, and Nymox Pharmaceutical Corp.

An effort in Sweden aimed at reducing inappropriate use of imaging to stage incident prostate cancer appears to be succeeding, and similar programs may help cut inappropriate imaging in the United States, researchers say.